Skip to content

Evaluating the effect of Chamomelin vaginal cream on the management of Vulvovaginal Candidiasis.

To compare the effect of Chamelin Ahoora Daroo vaginal cream (chamomile extract )and clotrimazol vaginal cream in the treatment of Vulvovaginal Candidiasis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016051118655N2
Enrollment
60
Registered
2016-10-13
Start date
2016-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulvovaginal Candidiasis. Candidiasis of Vulva and Vagina

Interventions

Intervention 1: case: Chamomeline Ahooradaroo Vaginal cream one applicator for ten nights. Intervention 2: control group: Clotrimazol Vaginal Cream one applicator for ten nights.
Treatment - Drugs
case: Chamomeline Ahooradaroo Vaginal cream one applicator for ten nights
control group: Clotrimazol Vaginal Cream one applicator for ten nights

Sponsors

Shiraz Univercity of Medical Sciences-infertility research center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women in reproductive age; with diagnosis of Vulvovaginal Candidiasis exclusion criteria: menopause; systemic disease; applying vaginal cream during the previous week .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Microscopic evaluation of the hypha in Vaginal secretion. Timepoint: Befor treatment and one week (ten nights) after applying the cream. Method of measurement: Count the hypha in each field.;Check the acidity of Vagina. Timepoint: Befor and during one week after treatment. Method of measurement: PH meter.

Secondary

MeasureTime frame
Signs and symptoms of Vulvovaginal Candidiasis. Timepoint: Before treatment and one week after ten nights applying the medication. Method of measurement: Evaluate the improvement and severity of signs and symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Poordast

Shiraz Univercity of Medical Sciences

ta.poordast@yahoo.com ? poordast@sums.ac.ir+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026